other material
confidence high
sentiment negative
materiality 0.65
Jupiter Neurosciences shareholders approve reverse stock split (1:10-1:100) and 5.25M share equity plan increase
JUPITER NEUROSCIENCES, INC.
- Shareholders approved reverse stock split at ratio between 1:10 and 1:100, with board discretion on timing and ratio.
- Equity incentive plan amended to increase authorized shares by 5,250,000 shares.
- All seven director nominees elected; Cherry Bekaert ratified as auditor for FY2026.
- Under SEPA with Yorkville, ~$1.5M convertible notes outstanding; ~12.5M shares issued for ~$4.1M net proceeds.